SQUAMOUS CELL CARCINOMA

This study tested a new device that delivers radiation directly to the skin to treat early-stage basal or squamous cell carcinoma. It involved 36 adults aged 60 or older. The goal was to see how well the device controls the cancer, its safety, and how the skin looks after treatme…

This early-phase study tested an experimental drug called rigosertib in just 2 people who have a rare, severe blistering skin disease (recessive dystrophic epidermolysis bullosa) and also developed advanced skin cancer. The goal was to see if the drug could shrink or control the …

This early-phase trial tested adding the immunotherapy drug pembrolizumab to standard chemoradiation for people with advanced head and neck cancer. 59 participants received the combination to see if it was safe and how well it worked. The goal was to improve tumor control without…

This early-phase trial tested a combination of two drugs, IRX-2 and durvalumab, in 19 people with advanced head and neck cancer that could not be cured with standard treatments. The goal was to see if the combination was safe and could boost the immune system's attack on tumors. …

This study looked at whether adding cetuximab to avelumab works better than avelumab alone for people with advanced head and neck cancer that has come back or spread. The cancer in these patients is not curable, and average survival is less than a year. The trial first checked th…

This study tested whether quercetin, a natural substance found in some foods, could help prevent a type of mouth cancer in people with Fanconi anemia, a rare genetic condition that raises cancer risk. 48 participants took quercetin to see if it reduced certain cell changes linked…

This study looked at whether telling people about their genetic risk for melanoma (a serious skin cancer) changes how they protect themselves from the sun. Over 2,000 adults took part and reported their sun habits, like using sunscreen and wearing hats, before and after learning …